Varicose Veins Treatment Devices Market Size & Growth Forecast 2026–2035, By Segments (Type, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Varicose Veins Treatment Devices Market size was assessed at USD 1.52 Billion in 2025 and is poised to grow at a 6.4% CAGR between 2026 and 2035, crossing USD 2.83 Billion by 2035. The industry revenue for 2026 is estimated at USD 1.61 billion.

• Base Year Value (2025): USD 1.52 Billion
• CAGR (2026-2035): 6.4%
• Forecast Year Value (2035): USD 2.83 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Varicose Veins Treatment Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America accounted for 47.70% of the market in 2025, supported by established vascular care pathways, broad access to minimally invasive procedures, and consistent demand across clinics and hospitals.
  • Asia Pacific is projected to grow at a 7.23% CAGR as access to vascular treatment improves, minimally invasive procedures gain wider acceptance, and healthcare providers expand treatment capacity.

• Segment Momentum:

  • Sclerotherapy held a 67.9% share in 2025 due to its established use for treating smaller varicose and spider veins, along with its suitability for efficient, office-based treatment workflows.
  • Ambulatory Care Units are expanding rapidly as minimally invasive vein procedures increasingly shift to outpatient settings that offer efficient workflows, shorter patient turnaround times, and convenient treatment access.

• Market Expansion Drivers:

  • Aging population and rising venous disease prevalence increasing treatment demand globally.
  • Growing preference for minimally invasive vein treatment procedures improving patient outcomes.
  • Expansion of outpatient vascular clinics and aesthetic vein correction services.

• Leading Market Participants:

  Top companies in the varicose veins treatment devices market include Medtronic plc (Ireland), Boston Scientific Corporation (United States), AngioDynamics, Inc. (United States), Teleflex Incorporated (United States), Merit Medical Systems, Inc. (United States), Biolitec AG (Austria), Sciton, Inc. (United States), Alma Lasers Ltd. (Israel), Dornier MedTech GmbH (Germany), Syneron Medical Ltd. (Israel).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 1.52 Billion
  • Projected Market Size: USD 2.83 Billion by 2035
  • Growth Forecasts: 6.4% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Sclerotherapy (Type) | Hospitals (End Use)
  • Emerging Opportunity Segment: Endovenous Ablation (Type) | Ambulatory Care Unit (End Use)

Market Growth Drivers and Industry Trends

Aging population and rising venous disease prevalence increasing treatment demand globally

As populations age, the incidence of chronic venous insufficiency, varicose veins, and related circulatory complications rises, creating a larger pool of patients who move from symptom management to procedural intervention. In the varicose veins treatment devices market, this shifts purchasing toward devices used in repeatable, office-based and hospital-led vein closure procedures, as clinicians face higher caseloads tied to pain, swelling, ulcer risk, and cosmetic concern. Rising disease prevalence also changes referral patterns, with primary care and vascular specialists identifying venous disorders earlier, which supports market expansion by increasing the number of patients evaluated and treated rather than left on conservative therapies alone.

Growing preference for minimally invasive vein treatment procedures improving patient outcomes

Patient and physician preference has increasingly moved away from surgical vein stripping toward minimally invasive approaches that reduce recovery time, procedural discomfort, and visible scarring while allowing faster return to daily activity. This dynamic is influencing market adoption in the varicose veins treatment devices market by favoring technologies such as endovenous ablation, sclerotherapy delivery systems, and image-guided treatment tools that fit modern clinical expectations for efficient, lower-burden care. Provider decision-making also follows outcomes and workflow advantages, since procedures with shorter treatment times and fewer post-operative demands are easier to integrate into routine vascular practice, reinforcing market demand for device-based interventions over more invasive alternatives.

Expansion of outpatient vascular clinics and aesthetic vein correction services

The growth of specialized outpatient vascular centers and cosmetic vein practices is changing where varicose vein procedures are performed and who is actively offering them. In the varicose veins treatment devices market, this broadens the installed base beyond large hospitals by creating steady demand from clinics that need compact, procedure-ready systems suited to high-throughput treatment settings. Aesthetic vein correction services also bring in patients earlier in the treatment journey, including those motivated by appearance before severe medical progression, which increases market penetration by expanding the addressable treatment population and normalizing elective, device-driven vein care as a routine outpatient service.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of venous disorders & aging population	2.40%	Short term (≤ 2 yrs)	North America, Europe (spillover: Asia Pacific)	High	Fast
Increasing adoption of minimally invasive treatment devices	2.10%	Medium term (2–5 yrs)	Asia Pacific, North America (spillover: Europe)	Medium	Moderate
Advances in laser & radiofrequency ablation therapies	1.70%	Long term (5+ yrs)	Europe, Asia Pacific (spillover: North America)	Medium	Slow
Aging population and rising venous disease prevalence increasing treatment demand globally	2.00%	Low	Europe, North America, Asia Pacific	High	Near Term
Growing preference for minimally invasive vein treatment procedures improving patient outcomes	1.50%	Moderate	North America, Europe	High	Near Term
Expansion of outpatient vascular clinics and aesthetic vein correction services	1.00%	Low	Asia Pacific, Europe	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading regional position in 2025, accounting for a 47.70% share of the varicose veins treatment devices market. This leadership is underpinned by established vascular care pathways, broad availability of minimally invasive treatment options, and strong utilization across specialized clinics and hospital settings. Market activity is aided by routine diagnosis and intervention for chronic venous disorders, where device-based procedures such as ablation and related treatments are integrated into standard practice, supporting consistent demand across the region.

Asia Pacific is projected to expand at a 7.23% CAGR over the forecast period in the varicose veins treatment devices market, driven by improving access to vascular treatment services and rising adoption of minimally invasive procedures in urban healthcare centers. Growth is being fueled by expanding treatment capacity, greater patient willingness to undergo device-based vein procedures, and the gradual spread of advanced care capabilities beyond the most developed markets. As providers increase procedural volumes and modernize treatment delivery, regional demand is accelerating in practical, procedure-led settings.

Key Country Insights

United States

Outpatient Procedure Focus

The U.S. market emphasizes minimally invasive varicose vein treatment devices that support outpatient procedures and faster patient recovery. Healthcare providers continue expanding adoption of image-guided technologies and integrated treatment platforms to improve procedural efficiency.

Japan

Aging Care Integration

Japan is strengthening the use of varicose vein treatment devices as demand grows for therapies suited to an aging patient population. Providers are focusing on minimally invasive solutions that reduce recovery time while supporting efficient clinical workflows.

South Korea

Technology-Driven Vein Care

South Korea is incorporating advanced imaging and catheter-based technologies into varicose vein treatment practices. Medical providers are adopting devices that improve procedural precision while supporting high-volume vascular treatment centers.

Germany

Precision Treatment Standards

Germany prioritizes clinically validated varicose vein treatment devices that align with stringent vascular care standards. Hospitals and specialist clinics are investing in advanced ablation systems and procedural consistency to enhance treatment quality.

France

Hospital Modernization Focus

France continues upgrading vascular treatment capabilities through adoption of modern varicose vein treatment devices in hospital and specialty settings. Procurement priorities favor reliable systems that support standardized minimally invasive interventions.

Italy

Specialist Clinic Expansion

Italy is seeing broader adoption of varicose vein treatment devices across specialized vascular clinics seeking efficient minimally invasive procedures. Healthcare providers are prioritizing equipment that supports patient comfort and streamlined treatment pathways.

Segment Leadership and Growth Trends

  Type Segment Analysis: Sclerotherapy (Largest Segment) vs Endovenous Ablation (Fastest-Growing Segment)

Within the varicose veins treatment devices market, sclerotherapy held a 67.9% share in 2025, reflecting its established role in routine vein treatment across a broad patient base. its position is underpinned by consistent clinical use in treating smaller varicose and spider veins, along with its fit in office-based care settings where procedural simplicity and repeatable treatment workflows support continued demand. The segment’s strong share also reflects how deeply embedded sclerotherapy is in standard treatment pathways for patients who do not require more device-intensive intervention.

Endovenous ablation is emerging as the fastest-growing segment in the varicose veins treatment devices market because treatment preferences are shifting toward minimally invasive options that can address symptomatic venous insufficiency with more targeted procedural control. Growth is being aided by increasing adoption in cases where clinicians seek an alternative to conventional approaches with streamlined recovery and stronger suitability for larger incompetent veins. Relative to other treatment types, endovenous ablation is gaining momentum as providers expand procedural capabilities and patients increasingly favor less disruptive interventions.

End Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Care Unit (Fastest-Growing Segment)

Hospitals accounted for the largest share of the varicose veins treatment devices market in 2025, aided by their ability to manage a wide range of vein procedures within integrated care environments. Their leading share is reinforced by access to multidisciplinary specialists, procedural infrastructure, and the capacity to treat patients requiring diagnostic evaluation and intervention in the same setting. This makes hospitals a dependable end-use channel for varicose veins treatment devices, particularly where treatment decisions are tied to broader vascular care pathways.

Ambulatory care unit is the fastest-growing end-use segment in the varicose veins treatment devices market as vein procedures increasingly move toward outpatient settings built around efficiency and shorter patient turnaround times. Growth is being encouraged by the practical fit between minimally invasive treatment methods and care models that reduce facility burden while maintaining procedural accessibility. Compared with traditional inpatient-oriented settings, ambulatory care units are experiencing stronger uptake because they align more closely with evolving provider workflows and patient expectations for convenient treatment.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Type	Endovenous Ablation, Sclerotherapy, Surgical Ligation & Stripping	Sclerotherapy	Endovenous Ablation
End Use	Vein Clinics, Hospitals, Ambulatory Care Unit	Hospitals	Ambulatory Care Unit

Competitive Landscape and Market Positioning

Leading companies in the varicose veins treatment devices market:

1. Medtronic plc (Ireland)

2. Boston Scientific Corporation (United States)

3. AngioDynamics Inc. (United States)

4. Teleflex Incorporated (United States)

5. Merit Medical Systems Inc. (United States)

6. Biolitec AG (Austria)

7. Sciton Inc. (United States)

8. Alma Lasers Ltd. (Israel)

9. Dornier MedTech GmbH (Germany)

10. Syneron Medical Ltd. (Israel)

In the varicose veins treatment devices market, minimally invasive approaches are gaining strong traction due to patient preference for faster recovery solutions. Device innovation is focusing on improving precision and treatment outcomes. The varicose veins treatment devices market continues to evolve with enhanced procedural efficiency and patient-centric care models.